cataract?glaucoma
Conditions
Interventions
Patients with coexisting glaucoma and cataract group:None
Sponsors
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Age 50 to 85 years old (including 50 and 85 years old), no gender restrictions; 2.Meet the diagnostic criteria for glaucoma and cataracts; 3.Patients scheduled for cataract phacoemulsification with intraocular lens implantation, who may also undergo concomitant glaucoma-related procedures (e.g., trabeculectomy, goniotomy, or drainage device implantation); 4.Able and willing to adhere to all follow-up schedules; 5.Voluntarily agree to participate in this study and provide written informed consent, unless exempted from informed consent following ethics committee approval.
Exclusion criteria
Exclusion criteria: 1.Systemic diseases that may affect postoperative outcomes, such as patients with unstable blood glucose control in diabetes; 2.Amblyopia, strabismus, corneal diseases, severe retinal diseases, and other ocular conditions that may compromise postoperative results; 3.History of ocular trauma or prior ocular surgeries that may confound observation findings; 4.Pregnant or lactating women; 5.Current or past history of traumatic brain injury, cerebrovascular disease (e.g., stroke), neurological disorders (e.g., epilepsy, Alzheimer's disease, Parkinson's disease), or psychiatric conditions (e.g., depression, schizophrenia); 6.History of alcohol dependence or substance abuse; 7.Presence of depressive symptoms, intellectual impairment, dementia symptoms, or sleep disorder symptoms; 8.Working memory capacity below 3 or inability to complete working memory tasks; 9.Claustrophobia or metallic implants that do not meet MRI safety standards; 10.Inability to comply with follow-up appointments as directed; 11.Other circumstances where the investigator determines the patient is unsuitable for enrollment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Functional Magnetic Resonance Imaging (fMRI);Electroencephalography (EEG) data; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in visual acuity, subjective refraction, intraocular pressure, slit-lamp examination, and iTrace examination results compared to pre-operation; | — |
Countries
China
Contacts
Public ContactGuo Tao
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Outcome results
None listed